NewsBenzinga아카디아, 레믈리판세린의 알츠하이머 정신병 3상 임상 진입 추진···주요 평가 지표 근소한 차이로 미달 아카디아, 레믈리판세린의 알츠하이머 정신병 3상 임상 진입 추진···주요 평가 지표 근소한 차이로 미달 Benzinga 2026.09.24 11:04 (GMT+0) Open on Benzinga Other news Google, OpenAI and Anthropic's AI safety organization is taking shape AJ Scaramucci's Solari Capital emerges from stealth, deploying about $350 million into AI and other sectors Oracle’s stock is falling as investors fear a data-center setback Atlassian: A $140 Billion Market Growing At 14% Annually Creates A Massive Opportunity Australia to investigate if OpenAI hack of government health website broke the law Is Jack Henry & Associates Stock Underperforming the Dow?
AJ Scaramucci's Solari Capital emerges from stealth, deploying about $350 million into AI and other sectors
